J&J Vows to Fix Manufacturing Problems as Scrutiny Grows
According to the Associated Press, Johnson & Johnson has hired an outside consulting firm to help fix manufacturing problems that triggered a massive recall of children''s medicines and which have drawn ire from federal lawmakers and regulators. The maker of Tylenol, Motrin and other medications laid out plans to restructure its manufacturing operations in the wake of the latest in a series of recalls that have tarnished the company''s household brands. In a posting to employees on its Web site, J&J''s McNeil Consumer Healthcare unit said it will share its action plan with the Food and Drug Administration by mid-July. The announcement comes on the same day the FDA ratcheted up scrutiny of J&J, issuing the company a warning letter about lax procedures at a plant that makes sterilization tools. Colleen Goggins, J&J''s president for consumer products, is scheduled to testify before a House committee on Thursday about a slew of manufacturing problems that triggered the recall of more than 40 medicines last month. FDA inspectors prodded J&J to recall the children''s medications after discovering the company had not looked into dozens of consumer complaints about "black or dark specks" in Tylenol and other products. FDA''s deputy commissioner is also scheduled to testify Thursday.